Learn how DLA, GSA’s Federal Acquisition Service and the State Department are modernizing their contract and acquisition ...

Gov. Jeff Landry’s proposed tax policy revamp went through further changes Tuesday in the Louisiana Legislature, with ...

Emmaus Life Sciences, Inc. ( OTCQB : EMMA) , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Ladies and gentlemen, greetings, and welcome to the KORU Medical ...

On October 31, 2024, the U.S. Department of Health and Human Services Office for Civil Rights (OCR) embraced the end of Spooky Season by ...

NASDAQ:HROW) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ETCompany ParticipantsJamie Webb - Director, Communications ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good day, and thank you for standing by. Welcome to the Q3 2024 Invivyd Earnings Conference Call. At this time, all participants are in a ...

Sensus Healthcare undertakes no obligation to revise or update any forward-looking statements, except as required by law. All forward-looking statements are subject to risks and uncertainties as ...

The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately 14% versus net Q2 2024 revenue of $2.7 ...

Received tentative approval from the FDA for YUTREPIATM (treprostinil) inhalation powder for both pulmonary arterial hypertension (PAH) ...

U.S. FDA approved Emrosi (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea in adults; launch expected in late Q1 or early Q2 of 2025 Tot ...